Improving pain management for advanced cancer using a smartphone app with therapy
Integrating pain-CBT into an mHealth analgesic support intervention for patients withchronic pain from advanced cancers
['FUNDING_CAREER'] · DANA-FARBER CANCER INST · NIH-11105914
This project creates a new smartphone app to help patients with advanced cancer manage their chronic pain by combining pain therapy with support for their medication.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DANA-FARBER CANCER INST (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11105914 on ClinicalTrials.gov |
What this research studies
Many patients with advanced cancer experience chronic pain, and traditional in-person therapy can be difficult to access. This project aims to develop a new smartphone application, called STAMP+CBT, that makes pain-focused cognitive behavioral therapy (CBT) more accessible. The app will integrate brief CBT techniques with an existing tool that helps patients monitor their symptoms and opioid medication. Our goal is to offer a convenient way for patients to receive both psychological and medical support for their pain.
Who could benefit from this research
Good fit: This work is designed for patients experiencing chronic pain due to advanced, incurable cancers who may benefit from combined behavioral and medication support.
Not a fit: Patients whose pain is not related to advanced cancer or who do not use smartphones may not directly benefit from this specific intervention.
Why it matters
Potential benefit: If successful, this app could provide a more convenient and integrated way for patients with advanced cancer to manage their chronic pain, potentially improving their quality of life.
How similar studies have performed: Mobile health technology has shown promise in delivering health interventions, and cognitive behavioral therapy is an established treatment for chronic pain, though this specific integration for advanced cancer is novel.
Where this research is happening
BOSTON, UNITED STATES
- DANA-FARBER CANCER INST — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HILTON, DESIREE R — DANA-FARBER CANCER INST
- Study coordinator: HILTON, DESIREE R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Advanced Cancer